Prevention of Gram-negative Bacterial Infections
This condition involves strategies and treatments aimed at preventing infections caused by Gram-negative bacteria, which can lead to serious health issues, especially in hospitalized patients.
RA0127: First-in-Human Safety Study
We are testing a new drug, RA0127, in healthy young volunteers to see if it is safe and well-tolerated. This study will help us understand how the drug affects people before further testing.
Safety phase (I)Infectious Diseases
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Del Mar
IMIM-Hospital del Mar
Barcelona, Spain
Sponsor: Remab Therapeutics S.L.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.